Notably, high mRNA expression of FAM3C was found to be independently associated with significantly shorter overall survival in glioma patients, even after accounting for clinical variables such as World Health Organization classification, tumor type, chemotherapy, and 1p19q status (Table 2). The gene discussed is FAM3C; the disease is central nervous system cancer.